COVIR - OCTOPUS BIOSAFETY ROBOT
Hello everyone, this new post I want to introduce about a very interesting and good project that is Covir, and for more details, let's just go to the following discussion:
The 2019–20 coronavirus pandemic is an ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognised as a pandemic by the World Health Organization (WHO) on 11 March 2020. As of 22 March, more than 321,000 cases of COVID-19 have been reported in over 180 countries and territories, resulting in more than 13,600 deaths.
About Covir
Covir.io is powered by Pagest.environnement SA registered in Geneva Switzerland.
Pagest.environnement SA was founded in 2000 ; K : 260 000 CHF and is active since. It is involved in sustainable devlopment projects, environment , green energy and biosecurity .
President Jacques Point is graduated from UNI Geneve and operated in green blockchain projects for many years.
About OCTOPUS ROBOTS
OCTOPUS ROBOTS is a French public limited company with a board of directors, active for 33 years. Located in CHOLET (49300) France, the company has always been specialized in high technologies (e.g. non-contact measuring systems).
In 2012, it moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) on various surfaces, with an innovative airborne disinfection system and sold it through a network of distributors worldwide.
Its objective is to micro-aerosolize/deliver liquid substances (biocides/sterilant, vaccines, phytosanitary and pest control products…) in the form of a dry fog to treat the whole space by moving the scattering sphere to get as close as possible to the target (efficient to treat large volumes such as public establishments “ERP” – airports, shopping malls, hospitals, etc.)
OCTOPUS ROBOTS & COVIR. IO
A robot designed to decontaminate equipment and large buildings such as food storage facilities and food processing plants, airport terminals, shopping malls and any other public buildings. Octopus Biosafety is a mobile, intelligent, fully autonomous and modular robot. Its unique atomization module delivers biocides in aerosolized form (ultramicroscopic particles) while getting away from temperature gradients and air flow issues that may negatively impact disinfection operation. It is a viable solution to fight Covid-19 by decontaminating public places. More at https://octopusrobots.com
BENEFITS
The digitalization of license fees, therefore of intangible assets, enabled by tokenization will allow better liquidity, mutualisation and greater openness of countries or geographic areas under negotiation. It will allow better efficiency enabled by technology, smart contracts which will automate the payment of royalties.
TOKENIZING OCTOPUS BIOSAFETY ROBOT LICENSING RIGHTS ON TEZOS BLOCKCHAIN
METRICS
Total valuation of the world licenses portfolio $ 160 Million
Potential Royalties ≈ $ 40 Million / year
The sale will be opened for 17-year i.e. sliding life of the patent or until the whole portfolio being sold
Creation of a printing capacity for 400,000,000 CVR.
The remaining 50% is an issue and sales reserve in order to supply the market until the contract is sold out and for a maximum of 17 years (Patent expires – Patend overwrite)
/!\ Please note that Covir does not hold any Token until printed from sales.
Tokenomics
CVR tokens are distributed on the Covir platform.
For all those disposing of a Tezos Wallet (XTZ) you will receive them directly on this one, once the address is registered and will be added to your Covir account.
CVR token holders will share 50% of the royalties invoiced by Octopus Robots, CVR may be used mainly for sale or purchase related to the disinfection activity. (Disinfectant, mask, diffuser, etc.)
Octopus Robot is a listed company, whose project supervised by Covir, ensures the reliability, financial security and the radiant future of the CVR.
Our goal is to create a solid ecosystem by selling only 30% of the total offer during our sales events (3 distinct stages).
Half of the CVR tokens not held (50%) will be reserved and used to supply the COVIR ecosystem over time (R&D, Greenshoe Option, new entrance to the covcom community). The remaining 20% will be allocated mainly to marketing, bonuses, reserves, the team and advisers, etc.
Major decisions or modifications will be submitted to the community demonstrating participative management (covcom).
The token sale revenue allocation will be the following:
75% – Octopus Robots (Website)
10% – Operational costs*
10% – Team & Advisors
5% – Reserve / Security Fund
*Marketing, server, exchange listing etc…
TEAM
To find more relevant details please follow several sources for the following references:
WEBSITE | WHITEPAPER | FACEBOOK | TWITTER | TELEGRAM |
Bitcointalk username: Sinseykoin